Gå till sökfältet
Gå till sidans huvudinnehåll
Gå till tillgänglighetsredogörelsen
Forskning.fi
Menu
Suomeksi
På svenska
In English
Ingångssida
Sökning
Vetenskaps- och innovationspolitik
Vetenskaps- och forskningsnyheter
Min profil
På svenska
- 11474 results
Publikationer
11474
Utlysningar
0
Beviljade finansiering
3
Personer
5
Data
1
Infrastrukturer
0
Organisationer
0
Projekt
0
Publikationer -
11 474
sökresultat
Gå till sökresultaten
Visa som bild
Begränsa sökning
Resultaten visas 1 - 10 / 11474
10
50
100
resultat / per sida
Vilka
publikations
uppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År
Recurrent CYP2C19 deletion allele is associated with
triple-negative
breast
cancer
Referentgranskad
Öppen tillgång
DOI
10.1186/1471-2407-14-902
Tervasmäki, Anna; Winqvist, Robert; Jukkola-Vuorinen, Arja; Pylkäs, Katri
Bmc
cancer
2014
Oncolytic virotherapy for treatment of
breast
cancer
, including
triple-negative
breast
cancer
Referentgranskad
Öppen tillgång
DOI
10.1080/2162402X.2015.1078057
Bramante, Simona; Koski, Anniina; Liikanen, Ilkka; Vassilev, Lotta; Oksanen, Minna; Siurala, Mikko; ...
Oncoimmunology
2016
Silibinin induces metabolic crisis in
triple-negative
breast
cancer
cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications
Referentgranskad
DOI
10.1111/febs.15353
Mohammad Askandar Iqbal; Shilpi Chattopadhyay; Farid Ahmad Siddiqui; Asad Ur Rehman; Shumaila Siddiq...
Febs journal
2020
Monoacylglycerol Lipase Inhibitor JJKK048 Ameliorates ABCG2 Transporter-Mediated Regorafenib Resistance Induced by Hypoxia in Triple Negative
Breast
Cancer
Cells
Referentgranskad
Öppen tillgång
DOI
10.1016/j.xphs.2023.05.012
Puris, Elena; Petralla, Sabrina; Auriola, Seppo; Kidron, Heidi; Fricker, Gert; Gynther, Mikko
Journal of pharmaceutical sciences
2023
CD73 in
triple-negative
breast
cancer
Öppen tillgång
Petruk Nataliia
University of Turku
2023
Chemical systems biology studies of triple negative
breast
cancer
cell lines
Öppen tillgång
Gautam, Prson
Dissertationes scholae doctoralis ad sanitatem investigandam universitatis helsinkiensis
2017
Neoadjuvant Camrelizumab for
Triple-Negative
Breast
Cancer
DOI
10.1001/jama.2024.25927
Joensuu, Heikki
JAMA : Journal of the American Medical Association
2025
FANCM mutation c.5791C > T is a risk factor for
triple-negative
breast
cancer
in the Finnish population
Referentgranskad
Öppen tillgång
DOI
10.1007/s10549-017-4388-0
Kiiski, Johanna I.; Tervasmäki, Anna; Pelttari, Liisa M.; Khan, Sofia; Mantere, Tuomo; Pylkäs, Katri...
Breast
cancer
research and treatment
2017
Light‐Activatable Assembled Nanoparticles to Improve Tumor Penetration and Eradicate Metastasis in Triple Negative
Breast
Cancer
Referentgranskad
Öppen tillgång
DOI
10.1002/adfm.201801738
Ji, Jianfeng; Ma, Fei; Zhang, Hongbo; Liu, Fengyong; He, Jian; Li, Wanlin; Xie, Tingting; Zhong, D...
Advanced functional materials
2018
Formin Proteins FHOD1 and INF2 in
Triple-Negative
Breast
Cancer
: Association With Basal Markers and Functional Activities
Referentgranskad
Öppen tillgång
DOI
10.1177/1178223418792247
Heuser, Vanina D.; Mansuri, Naziha; Mogg, Jasper; Kurki, Samu; Repo, Heli; Kronqvist, Pauliina; Carp...
Breast
cancer
2018
Recurrent CYP2C19 deletion allele is associated with
triple-negative
breast
cancer
Referentgranskad
Öppen tillgång
DOI
10.1186/1471-2407-14-902
2014
Oncolytic virotherapy for treatment of
breast
cancer
, including
triple-negative
breast
cancer
Referentgranskad
Öppen tillgång
DOI
10.1080/2162402X.2015.1078057
2016
Silibinin induces metabolic crisis in
triple-negative
breast
cancer
cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications
Referentgranskad
DOI
10.1111/febs.15353
2020
Monoacylglycerol Lipase Inhibitor JJKK048 Ameliorates ABCG2 Transporter-Mediated Regorafenib Resistance Induced by Hypoxia in Triple Negative
Breast
Cancer
Cells
Referentgranskad
Öppen tillgång
DOI
10.1016/j.xphs.2023.05.012
2023
CD73 in
triple-negative
breast
cancer
Öppen tillgång
2023
Chemical systems biology studies of triple negative
breast
cancer
cell lines
Öppen tillgång
2017
Neoadjuvant Camrelizumab for
Triple-Negative
Breast
Cancer
DOI
10.1001/jama.2024.25927
2025
FANCM mutation c.5791C > T is a risk factor for
triple-negative
breast
cancer
in the Finnish population
Referentgranskad
Öppen tillgång
DOI
10.1007/s10549-017-4388-0
2017
Light‐Activatable Assembled Nanoparticles to Improve Tumor Penetration and Eradicate Metastasis in Triple Negative
Breast
Cancer
Referentgranskad
Öppen tillgång
DOI
10.1002/adfm.201801738
2018
Formin Proteins FHOD1 and INF2 in
Triple-Negative
Breast
Cancer
: Association With Basal Markers and Functional Activities
Referentgranskad
Öppen tillgång
DOI
10.1177/1178223418792247
2018
Föregående
1
2
3
4
5
Nästa
Resultaten visas 1 - 10 / 11474
Sida 1
Sort